phase ii trial - Robuta Search

https://epub.ub.uni-muenchen.de/43740/ Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma phase ii trial primary cns lymphoma temsirolimus relapsed refractory https://yoda.yale.edu/clinical-trial/nct00708084-a-single-blind-randomized-monocentric-phase-ii-trial-to-explore-the-safety-and-rabies-neutralizing-activity-of-combined-administration-of-cl184-and-rabies-vaccine-versus-human-rabies-i/ NCT00708084 - A Single-blind, Randomized, Monocentric Phase II Trial to Explore the Safety and... phase ii trial single blind randomized monocentric explore https://adisinsight.springer.com/trials/700242476?error=cookies_not_supported&code=a37db516-8f53-4e13-b7c3-6f2a6bf92d38 Phase II trial to evaluate the safety and efficacy of inhaled alpha-1 antitrypsin (AAT) in patients... This phase II trial will investigate inhaled alpha-1 antitrypsin in patients with cystic fibrosis. phase ii trial evaluate safety efficacy inhaled https://cris.ariel.ac.il/en/publications/a-phase-ii-trial-of-belinostat-pxd101-in-patients-with-relapsed-o/fingerprints/ A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or... phase ii trial belinostat patients relapsed refractory https://www.patlynk.com/fr/trial/NCT00004198 A Phase II Trial to Evaluate the Rate of Immune Response Using Idiotype Immunotherapies Produced by... OBJECTIVES: I. Determine the ability of recombinant idiotype immunotherapy to stimulate a specific immune response against the B cell idiotype of the malignant phase ii trial immune response produced by evaluate rate https://scholarlyworks.lvhn.org/administration-leadership/9249/ "Long-term results of a phase II trial of ultrasound-guided radioactive" by Colleen A Lawton,... PURPOSE: To evaluate the long-term effectiveness of transrectal ultrasound-guided permanent radioactive I125 implantation of the prostate for organ confined... phase ii trial long term results ultrasound guided https://archbiopartners.com/2020/12/10/va-san-diego-healthcare-system-joins-the-phase-ii-trial-of-lsalt-peptide-for-the-treatment-of-complications-in-hospitalized-covid-19-patients/ VA San Diego Healthcare System Joins the Phase II Trial of LSALT Peptide for the Treatment of... phase ii trial san diego healthcare system joins peptide https://pyxisoncology.com/resource/a-phase-ii-trial-with-a-safety-lead-in-to-evaluate-the-addition-of-apx005m-a-cd40-agonistic-monoclonal-antibody-to-standard-of-care-doxorubicin-for-the-treatment-of-patients-with-advanced-sarcoma/ A Phase II Trial with a Safety Lead-in to Evaluate the Addition of APX005M, a CD40 Agonistic... phase ii trial lead in safety evaluate addition https://news.dailymushroom.co/filament-health-announces-health-canada-approval-for-phase-ii-trial-administering-new-psilocybin-microdose-formulation/ Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin... phase ii trial filament health announces canada https://www.cancer.columbia.edu/cancer-types-care/clinical-trials/find-clinical-trial/exact-randomized-phase-ii-trial-xl092-combination-immunotherapy-patients-who-progress-adjuvant-therapy-clear-cell-rcc EXACT: Randomized phase II trial of XL092 in combination with immunotherapy in patients who... Oct 8, 2026 - The purpose of this study is to see if study drug XL092 alone or in combination with nivolumab can treat your cancer after your cancer has progressed on... phase ii trial exact randomized combination immunotherapy https://scholar.usuhs.edu/en/publications/phase-ii-trial-of-bevacizumab-in-recurrent-or-persistent-endometr/ Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: A gynecologic oncology... phase ii trial endometrial cancer gynecologic oncology bevacizumab recurrent https://www.patlynk.com/trial/NCT00004856 A Phase II Trial of Trastuzumab (Herceptin; NSC #688097, IND #6667) in Patients With Previously... OBJECTIVES: I. Determine the response rate in patients with previously treated, locally advanced or metastatic transitional cell carcinoma of the urothelium tre phase ii trial trastuzumab herceptin nsc ind https://www.trinitydelta.org/initiation-of-china-phase-ii-trial-of-hmpl-453-in-advanced-malignant-mesothelioma/ Trinity Delta Initiation of China Phase II trial of HMPL-453 in advanced malignant mesothelioma -... phase ii trial malignant mesothelioma trinity delta initiation https://www.clinicaltrialsarena.com/news/cerecin-presents-findings-from-phase-ii-trial-for-tricaprilin/ Cerecin presents findings from Phase II trial for tricaprilin - Clinical Trials Arena Jul 3, 2023 - The findings show that the treatment might benefit those experiencing migraine. phase ii trial clinical trials presents findings arena https://www.egms.de/static/de/meetings/dkk2006/06dkk449.shtml GMS | 27. Deutscher Krebskongress | Phase II trial of Docetaxel and Carboplatinum in recurrent... phase ii trial gms deutscher docetaxel carboplatinum https://pure.johnshopkins.edu/en/publications/triumph-phase-ii-trial-of-rucaparib-monotherapy-in-patients-with-/ TRIUMPH: Phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive... phase ii trial triumph rucaparib monotherapy patients https://www.healthcarefocusmontserrat.com/article/871902120-painreform-commences-development-for-ocuring-k-phase-ii-trial-layerbio-s-drop-less-sustained-release-ocular-therapy PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less... phase ii trial commences development drop less https://www.foodandbeveragenewsnetwork.com/article/946329168-hummingbird-bioscience-announces-first-patient-dosed-in-phase-ii-trial-of-hmbd-001-and-cetuximab-in-advanced-squamous-cell-cancers Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in... phase ii trial hummingbird bioscience announces first https://www.thecanadianreporter.com/article/946329168-hummingbird-bioscience-announces-first-patient-dosed-in-phase-ii-trial-of-hmbd-001-and-cetuximab-in-advanced-squamous-cell-cancers Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in... The Canadian Reporter is an online news publication focusing on the Canada: The top news stories from Canada phase ii trial hummingbird bioscience announces first https://epub.ub.uni-muenchen.de/43739/ Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the... phase ii trial open label randomized gdc novel https://www.patlynk.com/trial/NCT00004924 Phase II Trial of Irinotecan Plus Paclitaxel in Patients With Advanced Nonsmall Cell Lung Cancer |... OBJECTIVES: Determine the antitumor activity and toxicities of irinotecan and paclitaxel in patients with advanced non-small cell lung cancer. OUTLINE: Patie phase ii trial lung cancer irinotecan plus paclitaxel https://itbusinessnet.com/2023/06/biomea-fusion-to-present-late-breaking-data-from-ongoing-phase-ii-trial-covalent-111-evaluating-bmf-219-in-patients-with-type-2-diabetes-at-ada-2023/ Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating... phase ii trial biomea fusion present late https://www.asiapacificfinancedaily.com/article/946329168-hummingbird-bioscience-announces-first-patient-dosed-in-phase-ii-trial-of-hmbd-001-and-cetuximab-in-advanced-squamous-cell-cancers Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in... phase ii trial hummingbird bioscience announces first https://www.thecancerconsortium.org/2009/12/thrombogenics-starts-phase-ii-trial-for-macular-degeneration-therapy/ ThromboGenics Starts Phase II Trial for Macular Degeneration Therapy – The Cancer Consortium phase ii trial macular degeneration starts therapy cancer https://www.prnewswire.co.uk/news-releases/bergenbio-enters-second-stage-of-phase-ii-trial-with-selective-axl-inhibitor-bemcentinib-in-combination-with-keytruda-in-patients-with-advanced-nsclc-855501672.html BerGenBio Enters Second Stage of Phase II Trial With Selective AXL Inhibitor bemcentinib in... /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO) announces that the first patient has been dosed in the second stage of the phase II trial (BGBC008) evaluating the... phase ii trial second stage axl inhibitor enters selective https://credevo.com/articles/2026/09/05/full-service-cro-apac-a-sponsors-guide-to-phase-ii-to-iv-clinical-trial-management/ Full Service CRO APAC: Phase II to IV Trial Management| Credevo Articles Jul 23, 2026 - What full service CRO APAC delivery covers for Phase II to IV trials: regulatory frameworks, site start-up, monitoring, and partner selection. full service phase ii cro apac trial https://profiles.umassmed.edu/display/46847995 Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated... phase ii trial paclitaxel carboplatin topotecan csf https://www.technologyreviewdjibouti.com/article/904675982-kainova-therapeutics-expands-phase-i-ii-trial-of-dt-7012-a-treg-depleting-anti-ccr8-antibody-with-first-patient-dosed-in-europe Kainova Therapeutics Expands Phase I/II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with... phase i therapeutics expands trial treg https://www.patlynk.com/trial/NCT00004412 Phase II Trial of Arginine Butyrate for Treatment of Refractory Leg Ulcers in Sickle Cell Disease... PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to one of two treatment arms. Arm I: Patients receive arginine butyrate IV ov phase ii trial sickle cell disease leg ulcers arginine butyrate https://acadia.com/en-us/media/news-releases/acadia-pharmaceuticals-present-data-its-phase-ii-trial ACADIA Pharmaceuticals to Present Data from Its Phase II Trial with Pimavanserin for Parkinson's... SAN DIEGO—(BUSINESS WIRE)—April 16, 2008—ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug... phase ii trial acadia pharmaceuticals present data pimavanserin https://scholars.duke.edu/publication/1110523 Scholars@Duke publication: Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by... phase ii trial followed by scholars duke publication https://www.patlynk.com/trial/NCT00001065 A Phase II Trial of Amphotericin B Oral Suspension for Fluconazole-Resistant Oral Candidiasis in... Experience with amphotericin B oral suspension for drug-sensitive thrush in HIV-infected patients is limited but encouraging. Patients swish and swallow amphote phase ii trial amphotericin b oral suspension fluconazole https://pure.fujita-hu.ac.jp/ja/publications/a-phase-ii-trial-of-ifosfamide-combination-with-recommended-suppo/ A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC... phase ii trial supportive therapy ifosfamide combination recommended https://www.patlynk.com/fr/trial/NCT00001398 A Phase I/II Trial of Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) in Patients... This trial, sponsored by Amgen, Inc., which produces the recombinant methionyl human stem cell factor (r-metHuSCF), also involves two other institutions. The pr stem cell factor phase i trial recombinant methionyl